Sequence Bio

Sequence Bio is a biotechnology company leveraging the founder effect in the province to identify true signals of disease, powering life-changing medicines; by integrating multi-omics from founder populations, real-world patient data, and well-characterized phenotypes, we are adopting a systems biology approach to discover better drug targets faster, helping to accelerate the development of new drugs to meet unmet medical needs worldwide; Sequence Bio is leading the NL Genome Project.